Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers define link between eosinophils and asthma

17.09.2004


Mayo Clinic researchers have used a comparative genomic strategy to demonstrate a causative link between eosinophils, a rare type of white blood cell, and asthma. Their research shows that the presence of these unique blood cells is absolutely required for the development of asthma. The details of this animal-based study appear in the Sept. 17, 2004, issue of Science, the journal of the American Association for the Advancement of Science (AAAS).



For more than a century, scientists have known that eosinophils are often the dominant inflammatory cells present in the lungs of asthma patients, but the importance of these white blood cells has been poorly understood with some studies even discounting a role for these cells. This new study demonstrates that eosinophils are required for the mucus accumulation and the lung dysfunction associated with asthma.

Using the tools of genomics, Mayo Clinic researchers have engineered a mouse that is specifically devoid of eosinophils, but otherwise has a full complement of blood-derived cells. Disease symptoms in these transgenic mice were dramatically reduced, and in some cases completely eliminated, following exposure to an allergen that in normal animals leads to asthma.


The development of a unique and novel transgenic mouse model without eosinophils now permits a definitive assessment of a number of human diseases besides asthma that have been linked to this white blood cell, including allergic diseases, parasite infections and cancer.

"Demonstrating that the eosinophil, a rare and often ignored cell, is a central mediator in the inflammation associated with asthma is a very important finding," says James J. Lee, Ph.D., director, Special Animal Services Laboratory at Mayo Clinic in Scottsdale, Ariz. "The outcomes of this study suggest the possibility of developing novel therapies and pharmaceuticals to treat and/or prevent asthma."

The Study

Researchers at Mayo Clinic Scottsdale created genetically-engineered transgenic mice that selectively express a toxic "suicide" gene, diphtheria toxin A, in bone marrow stem cells that go on to become circulating eosinophils in the blood. As a result of the selective expression of this toxin, unique marrow stem cells are eliminated and eosinophils never appear in circulation. The resulting mice have a normal complement of all red and white blood cell types except they are uniquely devoid of eosinophils.

Lung disease studies were conducted by comparing the responses of these transgenic mice without eosinophils relative to normal animals that contain eosinophils following exposure to an airborne allergen that provoked symptoms characteristic of asthma.

Significance of the Discovery

This study clearly shows that eosinophil activities are important contributing factors leading to symptoms classically defined as hallmark features of asthma. Future medical genomics studies will seek to confirm these findings in asthma patients and to further define the role of eosinophils in human disease, thereby widening the understanding of the principle causes of asthma and leading to targeted therapeutic approaches previously dismissed or overlooked. Because no known human patients or naturally occurring mutations in the mouse have been reported to be deficient of eosinophils without other additional consequences, this transgenic mouse model represents an important opportunity to define unambiguously the specific role of eosinophils in many diseases.

Participants in the Study

In addition to Dr. James J. Lee, others involved in the research include Dawn Dimina; MiMi P. Macias, PhD; Sergei I. Ochkur, PhD; Michael P. McGarry, PhD; Katie R. O’Neill, PhD; Cheryl Protheroe; Ralph Pero; Thanh Nguyen, M.D.; Stephania A. Cormier, PhD; Elizabeth Lenkiewicz; Dana Colbert; Lisa Rinaldi; Steven J. Ackerman, PhD; Charles G. Irvin, PhD; and Nancy A. Lee, PhD.

Support

The research was supported by grants from the Mayo Foundation, the American Heart Association, and the National Institutes of Health.

Bob Nellis | EurekAlert!
Further information:
http://www.mayo.edu

More articles from Life Sciences:

nachricht Good preparation is half the digestion
15.11.2018 | Max-Planck-Institut für Stoffwechselforschung

nachricht How the gut ‘talks’ to brown fat
16.11.2018 | Technische Universität München

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

NASA keeps watch over space explosions

16.11.2018 | Physics and Astronomy

UNH scientists help provide first-ever views of elusive energy explosion

16.11.2018 | Physics and Astronomy

How the gut ‘talks’ to brown fat

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>